Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical Development
08 juil. 2024 02h00 HE
|
Myricx Bio
£90m ($114m) series A co-led by new leading life science investors Novo Holdings and AbingworthAdditional new investors British Patient Capital, Cancer Research Horizons and Lilly participated...
Global Continuing Medical Education Market to Reach USD 18.45 billion by 2032, Experiencing Steady Growth at a 7.72% CAGR | Straits Research
04 juil. 2024 09h35 HE
|
Straits Research Private Limited - Garner Insights
New York, United States, July 04, 2024 (GLOBE NEWSWIRE) -- As per the latest report by Straits Research, the global continuing medical education market size was valued at USD 9.45 billion in 2023....
ICPO Foundation kooperiert mit Nuclear Medicine Research Infrastructure (NuMeRI), um ein ICPO Collaborating Center zu etablieren
04 juil. 2024 00h00 HE
|
ICPO Foundation
Diese Zusammenarbeit verbessert die globalen Bildungsstandards in der Radiotheranostik und zielt darauf ab, den Zugang der Patienten zu einer neuen Ära effektiver Krebstherapien in Südafrika zu...
ICPO Foundation partners with Nuclear Medicine Research Infrastructure (NuMeRI) to establish an ICPO Collaborating Center
04 juil. 2024 00h00 HE
|
ICPO Foundation
This collaboration enhances global educational benchmarks in radiotheranostics and aims to expand patient access to a new era of effective cancer therapeutics in South Africa. July 4, 2024 –...
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
03 juil. 2024 08h55 HE
|
AIM ImmunoTech Inc.
OCALA, Fla., July 03, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the next CEO Corner segment has been published on the Company’s...
Cross Keys Capital Advises New Jersey Cancer Care, PA, in Its Partnership with Regional Cancer Care Associates
02 juil. 2024 08h00 HE
|
Cross Keys Capital, LLC.
Fort Lauderdale, July 02, 2024 (GLOBE NEWSWIRE) -- Cross Keys Capital, LLC, a leading independent investment banking firm providing M&A advisory services to physician group practices and...
Global Cancer Diagnostics Market Size To Exceed USD 323.17 Billion By 2033 | CAGR of 8.71%
01 juil. 2024 20h00 HE
|
SPHERICAL INSIGHTS LLP
New York, United States , July 01, 2024 (GLOBE NEWSWIRE) -- The Global Cancer Diagnostics Market Size is to Grow from USD 140.25 Billion in 2023 to USD 323.17 Billion by 2033, at a CAGR of 8.71%...
Nipocalimab pivotal Phase 3 trial demonstrates sustained disease control in FcRn class for a broad population of myasthenia gravis patients
28 juin 2024 12h09 HE
|
Janssen Cilag International NV
First FcRn blocker to demonstrate superiority in Myasthenia Gravis - Activities of Daily Living score (MG-ADL) a over placebo when added to standard of care over 24 weeks in antibody positive...
Lantheus Acquires Global Rights to Life Molecular Imaging’s Novel Therapeutic and Diagnostic Pair Targeting GRPR for Prostate and Breast Cancers
27 juin 2024 07h05 HE
|
Lantheus Holdings, Inc.
BEDFORD, Mass., June 27, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight...
Save the date in your event calendar: Join and learn about the new era of cancer care at the ICPO Theranostics Virtual Summit, Nov 14 -15, 2024
27 juin 2024 00h00 HE
|
ICPO Foundation
Save the date in your event calendar: Join and learn about the new era of cancer care at the ICPO Theranostics Virtual Summit, Nov 14 -15, 2024 The ICPO Foundation offers a world-class scientific...